Lex phytoremedies "Diabefit" and "Chernika-Forte" in treatment and prevention of nonproliferative diabetic retinopathy
The paper presents the results of study of the clinical efficiency of «Diabefit» and «Chernika-Forte» in combination with basic pharmacotherapy of non-proliferative stage of diabetic retinopathy in 97 patients; applied traditional ophthalmological research methods. Depending on the treatment, patients were divided into 4 groups comparable on age, sex, type and duration of the disease: 1st group (21 patients), taking a basic pharmacotherapy; the 2nd — (24 patients), who took «Diabefit» in combination with basic pharmacotherapy; 3-rd group (23) — on the background of basic pharmacotherapy took «Chernika-Forte «; 4th group of patients (29), in the scheme of treatment received «Diabefit» and «Chernika-Forte «in combination with basic pharmacotherapy. The best anatomical and functional characteristics of the retina were observed in the 4th group of patients with diabetic retinopathy. The use of «Diabefit» and «Chernika-Forte» in combination with basic pharmacotherapy is a promising basic method of treatment of patients with micro-vascular complications of diabetes.